Clinical Trial Update: Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study [Phase 4]

View source ↗

Summary

Phase 4 pharmacogenomics study of anti-platelet intervention (PAPI-2) was terminated; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Syndrome

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Cardiovascular Diseases, Acute Coronary Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2016-06-28